结合血清IL-6、PGE2和TNF-α构建预测膀胱癌术后复发风险的 Nomogram模型
DOI:
CSTR:
作者:
作者单位:

作者简介:

通讯作者:

中图分类号:

基金项目:


Construction of' a Nomogram model combined with serum IL-6, PGE2, and TNF-a to predict the risk of postoperative recurrence of bladder cancer
Author:
Affiliation:

Fund Project:

  • 摘要
  • |
  • 图/表
  • |
  • 访问统计
  • |
  • 参考文献
  • |
  • 相似文献
  • |
  • 引证文献
  • |
  • 资源附件
  • |
  • 文章评论
    摘要:

    摘要:目的结合血清白细胞介素-6(IL-6)、前列腺素E2(PGE2)及肿瘤坏死因子-α(TNF-α)构建预测膀胱癌患者术后复发风险的Nomogram模型。方法选取2019年1月至2023年1月在杭州市临平区第一人民医院行手术治疗的膀胱癌患者240例。术后随访12~60个月以统计患者复发情况,并将复发患者纳入复发组,未复发患者纳入无复发组。进一步比较2组患者术前血清IL-6、PGE2和TNF-α的表达水平;采用多因素逐步Logistic回归分析法分析术后复发的影响因素,构建Nomogram模型并验证其预测效能。结果与无复发组比较,复发组患者术前血清IL-6、PGE2和TNF-α的表达水平升高(P0.06时提供了附加的临床净收益。结论术前血清IL-6、PGE2和TNF-α水平是膀胱癌患者术后复发的危险因素,据此构建的风险Nomogram预测模型具有良好的预测效能。

    Abstract:

    Abstract: Objective To construct a Nomogram model combined with serum interleukin-6(IL-6), prostaglandin E2(PGE2) and tumor necrosis factor-α (TNF-a) to predict the risk of postoperative recurrence of bladder cancer. MethodsA total of 24O patients with bladdercancer underwent surgeryin the First People's Hospital of Linping District fromJanuary2019 toJanuary2023were selected. The patients with recurrence were included in the recurrence group and those without recurrence were included in the non-recurrence group after 12 to 6O months of follow-up. The levels of serum IL-6, PGE2 and TNF-a before surgery between the two groups were compared. The influencing factors of postoperative recurrence were evaluated by the multivariate stepwise Logistic regression analysis. A Nomogram model was constructed and its predictive efficacy was verified. ResultsThe levels of preoperative serum IL-6, PGE2, and TNF-α in the recurrence group were significantly higher than those in the non-recurrence group (P

    参考文献
    相似文献
    引证文献
引用本文

李胜群,丁娟英,唐鹏.结合血清IL-6、PGE2和TNF-α构建预测膀胱癌术后复发风险的 Nomogram模型[J].临床检验杂志,2026,44(04):300-304

复制
分享
相关视频

文章指标
  • 点击次数:
  • 下载次数:
  • HTML阅读次数:
  • 引用次数:
历史
  • 收稿日期:2025-06-15
  • 最后修改日期:
  • 录用日期:
  • 在线发布日期: 2026-06-10
  • 出版日期:
文章二维码
您是第位访问者  苏ICP备13058113号-3
苏公网安备32010202012004号
主管单位:江苏省医学会  出版单位:临床检验杂志
单位地址:江苏省南京市中央路42号  邮编:210008
电话:025-83620683 E-MAIL:lcjyzz@163.com
技术支持:北京勤云科技发展有限公司